CG Oncology, Inc. Quarterly Operating Lease, Payments in USD from Q1 2023 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
CG Oncology, Inc. quarterly/annual Operating Lease, Payments history and growth rate from Q1 2023 to Q4 2024.
  • CG Oncology, Inc. Operating Lease, Payments for the quarter ending December 31, 2024 was $60K, a 5.26% increase year-over-year.
  • CG Oncology, Inc. Operating Lease, Payments for the twelve months ending December 31, 2024 was $223K, a 1.83% increase year-over-year.
  • CG Oncology, Inc. annual Operating Lease, Payments for 2024 was $223K, a 1.83% increase from 2023.
Operating Lease, Payments, Trailing 12 Months (USD)
Operating Lease, Payments, Quarterly (USD)
Operating Lease, Payments, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2024 $223K $60K +$3K +5.26% Oct 1, 2024 Dec 31, 2024 10-K 2025-03-28
Q3 2024 $220K $60K +$1K +1.7% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q2 2024 $219K $45K $0 0% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $219K $58K $0 0% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $219K $57K Oct 1, 2023 Dec 31, 2023 10-K 2025-03-28
Q3 2023 $59K Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 $45K Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 $58K Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.